Radiotherapy in Oligometastatic and Oligoprogressive Disease
PDF
Cite
Share
Request
Review
VOLUME: 33 ISSUE: 1
P: 1 - 6
2023

Radiotherapy in Oligometastatic and Oligoprogressive Disease

Anatol J Gen Med Res 2023;33(1):1-6
1. Sağlık Bilimleri Üniversitesi, İzmir Tepecik Eğitim ve Araştırma Hastanesi, Radyasyon Onkolojisi Kliniği, İzmir, Türkiye
2. Sağlık Bilimleri Üniversitesi, İzmir Tepecik Eğitim ve Araştırma Hastanesi, Medikal Onkolojisi Kliniği, İzmir, Türkiye
3. Sağlık Bilimleri Üniversitesi, İzmir Tepecik Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, İzmir, Türkiye
No information available.
No information available
Received Date: 2021-04-05T11:13:08
Accepted Date: 2023-04-10T13:36:07
PDF
Cite
Share
Request

Abstract

Oligometastasis is an intermediate group in the biological spectrum between localized disease and metastatic diseases. In terms of prognosis, it may present with a different course than common stage cases. There are many studies have showing the benefit of aggressive local therapy in these cases. In these studies, local treatment of all metastatic foci was shown to prolong survival in oligometastatic disease with primary control. In this review, the role of radiotherapy in oligometastatic disease is discussed considering studies.

Keywords:
Oligometastasis, oligoprogressive disease, radiotherapy, stereotaxic radiotherapy, tereotactic body radiotherapy